In a huge step forward for research into the prevention of T1D, JDRF yesterday announced that Dr Kirstine Bell will lead a pilot study to screen children for early signs of T1D. This study will be the first in Australia – and one of only three in the world – to screen people from the […]
Every month, we round up the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: T1D screening success in Germany […]
Every month, we will be rounding up the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that could make a big impact on your life. Here’s what you need to know in T1D research this month: A milestone for beta cell replacement In the […]
On International Women’s Day we would like to thank all the amazing women who have contributed to JDRF – volunteers, committee members, Board members and hardworking fundraisers. But in particular we would like to celebrate the achievements of one of JDRF’s most valued longstanding members and say congratulations to Gwennyth Baker who was awarded the […]
Funding will help support translate more innovations into useful treatments for people living with type 1 diabetes. JDRF welcomes the news today that the Liberal National Government has committed to continued support of the Type 1 Diabetes Clinical Research Network (CRN). The $54.5m over five years, will continue the work of the network, most recently supported by […]
A vaccine that protects infants from a nasty stomach virus may provide an unexpected bonus – helping to prevent type 1 diabetes. The rotavirus vaccine became a routine immunisation for Australian babies in 2007, and unlike some other countries, it’s had widespread uptake. The vaccine is given to babies aged two and four months to protect […]
Researchers at St Vincent’s Institute (SVI) in Melbourne led by JDRF Career Development Award recipient, Associate Professor Stuart Mannering, have identified a key target of the immune response that causes type 1 diabetes (T1D). We know that that T1D is caused by the immune system destroying insulin-producing beta cells, however the immune system is extremely […]
The JDRF-led Type 1 Diabetes Clinical Research Network is currently recruiting for a study which could help reduce eye complications for people with type 1 diabetes. See full study details here, or email the FAME-1 study team at fame1eye@ctc.usyd.edu.au.
People with type 1 diabetes (T1D) have to live with it 24 hours a day, 7 days a week, 365 days a year. But this year’s American Diabetes Association’s (ADA) 78th Scientific Sessions in Orlando, Florida brought hope and inspiration to people living with T1D. The ADA 78th Scientific Sessions highlighted some important JDRF-funded and JDRF-supported […]